These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
365 related articles for article (PubMed ID: 17419691)
1. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Lehmann P Br J Dermatol; 2007 May; 156(5):793-801. PubMed ID: 17419691 [TBL] [Abstract][Full Text] [Related]
2. Methyl aminolevulinate-PDT for actinic keratoses and superficial nonmelanoma skin cancers. Ortiz-Policarpio B; Lui H Skin Therapy Lett; 2009; 14(6):1-3. PubMed ID: 19609473 [TBL] [Abstract][Full Text] [Related]
3. Methyl-aminolevulinate photodynamic therapy for the treatment of actinic keratoses and non-melanoma skin cancers: a retrospective analysis of response in 462 patients. Fai D; Arpaia N; Romano I; Vestita M; Cassano N; Vena GA G Ital Dermatol Venereol; 2009 Jun; 144(3):281-5. PubMed ID: 19528909 [TBL] [Abstract][Full Text] [Related]
4. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer. de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503 [TBL] [Abstract][Full Text] [Related]
5. Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma. Annemans L; Caekelbergh K; Roelandts R; Boonen H; Leys C; Nikkels AF; van Den Haute V; van Quickenborne L; Verhaeghe E; Leroy B Eur J Dermatol; 2008; 18(5):539-46. PubMed ID: 18693157 [TBL] [Abstract][Full Text] [Related]
7. Methyl aminolaevulinate-photodynamic therapy for actinic keratoses, squamous cell carcinoma in situ and superficial basal cell carcinoma employing a square wave intense pulsed light device for photoactivation. Downs AM; Bower CB; Oliver DA; Stone CA Br J Dermatol; 2009 Jul; 161(1):189-90. PubMed ID: 19416229 [No Abstract] [Full Text] [Related]
8. The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up. Farhi D; Bedane C; Savary J; Basset-Seguin N Eur J Dermatol; 2013; 23(1):68-76. PubMed ID: 23400280 [TBL] [Abstract][Full Text] [Related]
9. Clinical and research applications of photodynamic therapy in dermatology: experience of the Scottish PDT Centre. Moseley H; Ibbotson S; Woods J; Brancaleon L; Lesar A; Goodman C; Ferguson J Lasers Surg Med; 2006 Jun; 38(5):403-16. PubMed ID: 16788933 [TBL] [Abstract][Full Text] [Related]
10. Aminolevulinic acid and methyl aminolevulinate equally effective in topical photodynamic therapy for non-melanoma skin cancers. Tarstedt M; Gillstedt M; Wennberg Larkö AM; Paoli J J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):420-3. PubMed ID: 26841041 [TBL] [Abstract][Full Text] [Related]
11. Economic evaluation of methyl aminolaevulinate-based photodynamic therapy in the management of actinic keratosis and basal cell carcinoma. Caekelbergh K; Annemans L; Lambert J; Roelandts R Br J Dermatol; 2006 Oct; 155(4):784-90. PubMed ID: 16965429 [TBL] [Abstract][Full Text] [Related]
12. Methylaminolaevulinate-based photodynamic therapy of Bowen's disease and squamous cell carcinoma. Calzavara-Pinton PG; Venturini M; Sala R; Capezzera R; Parrinello G; Specchia C; Zane C Br J Dermatol; 2008 Jul; 159(1):137-44. PubMed ID: 18489606 [TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy with violet light and topical 6-aminolaevulinic acid in the treatment of actinic keratosis, Bowen's disease and basal cell carcinoma. Dijkstra AT; Majoie IM; van Dongen JW; van Weelden H; van Vloten WA J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):550-4. PubMed ID: 11843215 [TBL] [Abstract][Full Text] [Related]
14. Intraindividual, right-left comparison of topical methyl aminolaevulinate-photodynamic therapy and cryotherapy in subjects with actinic keratoses: a multicentre, randomized controlled study. Morton C; Campbell S; Gupta G; Keohane S; Lear J; Zaki I; Walton S; Kerrouche N; Thomas G; Soto P; Br J Dermatol; 2006 Nov; 155(5):1029-36. PubMed ID: 17034536 [TBL] [Abstract][Full Text] [Related]
15. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. Braathen LR; Szeimies RM; Basset-Seguin N; Bissonnette R; Foley P; Pariser D; Roelandts R; Wennberg AM; Morton CA; J Am Acad Dermatol; 2007 Jan; 56(1):125-43. PubMed ID: 17190630 [TBL] [Abstract][Full Text] [Related]
16. Spotlighting the role of photodynamic therapy in cutaneous malignancy: an update and expansion. Ross K; Cherpelis B; Lien M; Fenske N Dermatol Surg; 2013 Dec; 39(12):1733-44. PubMed ID: 24118243 [TBL] [Abstract][Full Text] [Related]
17. Long-term recurrence of nonmelanoma skin cancer after topical methylaminolevulinate photodynamic therapy in a dermato-oncology department. Cabete J; Rafael M; Cravo M; Moura C; Sachse F; Pecegueiro M An Bras Dermatol; 2015; 90(6):846-50. PubMed ID: 26734866 [TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy: current evidence and applications in dermatology. Lee Y; Baron ED Semin Cutan Med Surg; 2011 Dec; 30(4):199-209. PubMed ID: 22123417 [TBL] [Abstract][Full Text] [Related]
20. Multicentre intraindividual randomized trial of topical methyl aminolaevulinate-photodynamic therapy vs. cryotherapy for multiple actinic keratoses on the extremities. Kaufmann R; Spelman L; Weightman W; Reifenberger J; Szeimies RM; Verhaeghe E; Kerrouche N; Sorba V; Villemagne H; Rhodes LE Br J Dermatol; 2008 May; 158(5):994-9. PubMed ID: 18341663 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]